Page 85 - ITPS-8-1

INNOSC Theranostics and
Pharmacological Sciences Anabolic agents in cancer cachexia

2. Evans WJ, Morley JE, Argiles J, et al. Cachexia: A new doi: 10.7150/ijbs.4125
definition. Clin Nutr. 2008;27(6):793-799.
14. Tsai CC, Yang YC, Chen YF, et al. Integrins and actions of
doi: 10.1016/j.clnu.2008.06.013 androgen in breast cancer. Cells. 2023;22(12):2126.
3. Johns N, Hatakeyama S, Stephens NA, et al. Clinical doi: 10.3390/cells12172126
classification of cancer cachexia: Phenotypic correlates in 15. Tirupula KC, Ithychanda SS, Mohan ML, Naga Prasad SV,
human skeletal muscle. PLoS One. 2014;9(1):e83618. Qin J, Karnik SS. G protein-coupled receptors directly
doi: 10.1371/journal.pone.0083618 bind filamin A with high affinity and promote filamin
phosphorylation. Biochemistry. 2015;54(44):6673-6683.
4. Vanhoutte G, van de Wiel M, Wouters K, et al. Cachexia in
cancer: What is in the definition? BMJ Open Gastroenterol. doi: 10.1021/acs.biochem.5b00975
2016;3(1):e000097. 16. Hopkins BD, Goncalves MD, Cantley LC. Insulin-PI K
3
doi: 10.1136/bmjgast-2016-000097 signalling: An evolutionarily insulated metabolic driver of
cancer. Nat Rev Endocrinol. 2020;16(5):276-283.
5. Ferlay J, Colombet M, Soerjomataram I, et al. Cancer
incidence and mortality patterns in Europe: Estimates for doi: 10.1038/s41574-020-0329-9
40 countries and 25 major cancers in 2018. Eur J Cancer. 17. Barrett A, Pellet-Many C, Zachary IC, Evans IM, Frankel P.
2018;103:356-387. p130Cas: A key signalling node in health and disease. Cell
doi: 10.1016/j.ejca.2018.07.005 Signal. 2013;25(4):766-777.
6. Lambert CP. Strength as a predictor of longevity: Compelling doi: 10.1016/j.cellsig.2012.12.019
evidence. J Mens Health. 2022;18(5):113. 18. Lambert C. Attenuating cancer cachexia-prolonging life. In:
Frailty and Sarcopenia-Recent Evidence and New Perspectives.
doi: 10.31083/j.jomh1805113
London: IntechOpen; 2021.
7. Jang MK, Park C, Hong S, Li H, Rhee E, Doorenbos AZ.
Skeletal muscle mass change during chemotherapy: 19. Bhasin S, Storer TW, Berman N, et al. The effects of
A systematic review and meta-analysis. Anticancer Res. supraphysiologic doses of testosterone on muscle size and
strength in normal men. N Engl J Med. 1996;335(1):1-7.
2020;40(5):2409-2418.
doi: 10.1056/NEJM199607043350101
doi: 10.21873/anticanres.14210
20. Wright TJ, Dillon EL, Durham WJ, et al. A randomized trial
8. Berg JM, Tymoczko JL, Gatto GJ, Stryer L. Biochemistry. of adjunct testosterone for cancer-related muscle loss in men
United States: W.H. Freeman; 2019.
and women. J Cachexia Sarcopenia Muscle. 2018;9(3):482-496.
9. Pihlajamaa P, Sahu B, Janne OA. Determinants of doi: 10.1002/jcsm.12295
receptor- and tissue-specific actions in androgen signaling.
Endocr Rev. 2015;36(4):357-384. 21. Wendler J. 5/3/1 for Powerlifting: Simple and Effective Training
for Maximal Strength. Ohio: Jim Wendler LLC; 2011.
doi: 10.1210/er.2015-1034
22. Viehweger F, Hoop J, Tinger LM, et al. Frequency of
10. Salinas I, Sinha N, Sen A. Androgen-induced epigenetic androgen receptor positivity in tumors: A study evaluating
modulations in the ovary. J Endocrinol. 2021;249(3):R53-R64. more than 18,000 tumors. Biomedicines. 2024;12(5):957.
doi: 10.1530/JOE-20-0578 doi: 10.3390/biomedicines12050957
11. Giovannelli P, Di Donato M, Giraldi T, Migliaccio A, 23. Uc EY, Lambert CP, Harik SI, Rodnitzky RL, Evans WJ.
Castoria G, Auricchio F. Targeting rapid action of sex- Albuterol improves response to levodopa and increases
steroid receptors in breast and prostate cancers. Front Biosci skeletal muscle mass in patients with fluctuating Parkinson
(Elite Ed). 2012;4(1):453-461. disease. Clin Neuropharmacol. 2003;26(4):207-212.
doi: 10.2741/e390 doi: 10.1097/00002826-200307000-00011
12. Pan CQ, Sudol M, Sheetz M, Low BC. Modularity and 24. Liu S, Anderson PJ, Rajagopal S, Lefkowitz RJ, Rockman HA.
functional plasticity of scaffold proteins as p(l)acemakers in G protein-coupled receptors: A century of research and
cell signaling. Cell Signal. 2012;24(11):2143-2165. discovery. Circ Res. 2024;135(1):174-197.
doi: 10.1016/j.cellsig.2012.06.002 doi: 10.1161/CIRCRESAHA.124.323067
13. Walsh CA, Qin L, Tien JC, Young LS, Xu J. The function of 25. Lambert CP. Effects of ß2-adrenergic agonists on skeletal
steroid receptor coactivator-1 in normal tissues and cancer. muscle hypertrophy and atrophy. In: Pharmacotherapy of
Int J Biol Sci. 2012;8(4):470-485. Cachexia. United States: CRC Press; 2005.

Volume 8 Issue 1 (2025) 79 doi: 10.36922/itps.4699